SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
The Single Most Important Metric To Determine If Valeant Is A Buy
September 16, 2016
 · 
1 min read
Deal Spree Continues as Allergan Inks $2.47 Billion Deal for This Bay Area Biotech
Deals
Could There be a Marriage Between Valeant and Allergan?
September 15, 2016
 · 
2 min read
Biotech Bay
Is Mylan The New Valeant?
August 29, 2016
 · 
1 min read
Months After Infamous 'Sexist' Biotech Party, 20 Women Join New Exec Training
Business
Valeant Offers Details on Incoming CFO’s Compensation; Will Get $10 Million in ‘Make-Up Cash’
August 24, 2016
 · 
2 min read
Anger Behind the Scenes When Valeant Jacked Up Price by 2,700% for Lead Poisoning Drug
Business
Embattled Valeant to Finally Reorganize, CEO Urges Patience
August 9, 2016
 · 
2 min read
Anger Behind the Scenes When Valeant Jacked Up Price by 2,700% for Lead Poisoning Drug
Deals
Valeant’s Constipation Drug Relistor Attracts Interest From Rivals, Sale Could Bring In $400-$500 Million
August 8, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
3 Battered Biopharma Stocks Battling to Recover
July 22, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
FDA Rejects Valeant Glaucoma Drug, Raises Concerns Over Manufacturing Issues
July 22, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
FDA Panel Divided on Valeant’s Psoriasis Drug Suicide Risk
July 18, 2016
 · 
2 min read
Load More
IN THE PRESS
Policy
Valeant Corrects Misleading Report About Salix Investigation
March 2, 2017
 · 
2 min read
Business
Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance
February 28, 2017
 · 
17 min read
Job Trends
Valeant’s Salix Beefs Up Workforce With 250 Sales Reps
February 27, 2017
 · 
3 min read
Business
Sobi Enters Into New Distribution Agreement With Valeant For Ammonul
February 21, 2017
 · 
2 min read
Business
Valeant And EyeGate Pharma Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients
February 21, 2017
 · 
5 min read
FDA
FDA Clears Valeant’s New Psoriasis Drug, But With Strings Attached
February 16, 2017
 · 
4 min read
Drug Development
Valeant Release: Pharma Company Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118
January 10, 2017
 · 
4 min read
Valeant Release: Bausch & Lomb Launches Expanded Parameters For For Presbyopia Contact Lenses
January 10, 2017
 · 
3 min read
Business
EyeGate Pharma Receives Additional Milestone Payment From Valeant For EGP-437
January 9, 2017
 · 
3 min read
Business
Valeant Announces Addition Of Richard U. DeSchutter To Its Board Of Directors
January 5, 2017
 · 
2 min read
Load More